SHMN SOHM INC

SOHM OTC Self-care Launches Suite of 13 New SOHM Nutrients’ Brand Chewables

SOHM OTC Self-care Launches Suite of 13 New SOHM Nutrients’ Brand Chewables

CHINO HILLS, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced:

SOHM OTC Self-care launches a suite of 13 new SOHM Nutrients’ Brand Chewables.

SOHM OTC Self-care business unit is launching its suite of 13 new SOHM Nutrients’ Brand Chewables into the global vitamin gummies market.

The global vitamins market is valued at $6.84 billion in 2022 and is expected to reach $18.76 billion by 2031 with a CAGR of 12.06% between 2023-2031. (CAGR, Compounded Annual Growth Rate.)

Source: 

Research and Markets report noted the drivers for the explosive growth of the global vitamin gummies include:

-- Global consumers gaining wealth and spending more on healthcare, self-care products

-- Health benefits (vitamins, minerals)

-- Taste (fruit flavors)

-- Convenience (pocket portability)

-- Access (no water needed)

The suite of these 13 SOHM Nutrients’ Brand Chewables will be offering consumers these key features:

-- Bone health, skin health, immune boost, mineral replenishment, and sleep aid

-- Convenience of individually wrapped single serving (pocket friendly)

-- Chewables (no water required)

-- Taste (mango, strawberry, pineapple, toffee)

These SOHM Nutrients’ Brand Chewables also boast the same sought-after ingredients and labels as the leading vitamin gummies on Amazon.com:

-- Turmeric, folic acid, multi-vitamins, multi-minerals

-- Nuts free

-- Gluten free

-- Gelatin free

-- Vegan

-- Soy free

“This launch of our suite of SOHM Nutrients’ Brand Chewables marks our commitment to continually building out a strong SOHM ‘Adds Life to Lives’ portfolio of products in preventive care segments. Going into 2024, we will be announcing additional OTC Self-care products launches to include our in-house manufactured products from the labs and production lines of our CDMO facilities located in San Diego, California. This launch will have an appreciable impact on our sales going forth,” says Dr. David Aguilar, PhD, COO of SOHM.

The 13 newly branded SOHM Nutrients’ Brand Chewables will be available for:

-- Retail purchases through Amazon.com, and

-- Retail and bulk purchases through the company’s Direct-to-Consumers Website.

The suite of SOHM Nutrients’ Brand Chewables are priced competitively to best-seller gummies on Amazon.com.

The company will be showcasing these newly branded SOHM Nutrients’ Brand Chewables at future consumer self-care product industry conferences in 2024.

Schedules for these industry conferences on East and West Coasts USA are still being finalized pending year-end budgeting.

About SOHM, Inc.

SOHM, Inc. is a growing generic pharmaceutical manufacturing and marketing company with a vision of “Globalè Prospèro” that aims to build continuous growth. SOHM manufacturing and marketing targets rapidly growing healthcare segments such as nutraceuticals, cosmeceuticals and other major therapeutic segments. SOHM is headquartered in North America with manufacturing alliances in India and strategic alliances with U.S. manufacturing facilities. Although SOHM’s generic pharmaceuticals are exported globally and were introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America and Southeast Asia.

To learn more about SOHM, Inc., visit

Safe Harbor Statement:

This news release contains “forward-looking statements,” which are statements that are not purely historical and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development-stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report for the most recent fiscal year and our quarterly reports uploaded from time to time on OTCMarkets.com.

For more information, please contact:

SOHM, Inc.

+1 (714) 522-6700

Corporate Communications:

InvestorBrandNetwork (IBN)

Los Angeles, California



+1 310.299.1717 Office



EN
14/11/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on SOHM INC

 PRESS RELEASE

SOHM, Inc., Targets Revolutionary New ABBIE Genome Editing Kits for Q3...

SOHM, Inc., Targets Revolutionary New ABBIE Genome Editing Kits for Q3, 2024 SOHM, Inc. Further Advances its Work in the Field of Genome Editing and ABBIE, a Retroviral Integrase with Linked Guided DNA Binding Domain CHINO HILLS, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN)– a leading generic pharmaceutical and upstart biotechnology company, is proud to announce its ongoing work on ABBIE (A Binding Based Integrase Enzyme), a revolutionary retroviral integrase with a linked dCas9 DNA binding domain. This groundbreaking technology has the potential to re...

 PRESS RELEASE

SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboratio...

SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboration to Revolutionize Genome Editing Using Red Blood Cell Membrane Derived Carriers CHINO HILLS, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today the collaboration with Coastar Therapeutics, San Diego, California, a leading biotechnology company specializing in innovative drug delivery systems, and SOHM, a cutting-edge biopharmaceutic...

 PRESS RELEASE

SOHM Files Provisional Patent on ABBIE’s ‘Smart Gene-Editing’ That Use...

SOHM Files Provisional Patent on ABBIE’s ‘Smart Gene-Editing’ That Uses Latest Enzymes and Guide RNA to Resolve Off-Target Gene-Editing Limitations CHINO HILLS, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN) (the “Company”), a pharmaceutical, nutraceutical, cosmeceutical and biotech Company that manufactures and markets generic drugs covering numerous treatment categories, announces today the Company has filed a provisional patent application on its ABBIE “Smart Gene-Editing” platform that uses the latest enzymes and guide RNAs to resolve off-target gene-...

 PRESS RELEASE

SOHM Announces Business Outlook for 2024

SOHM Announces Business Outlook for 2024 CHINO HILLS, Calif., Dec. 05, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN) (the “Company”), a pharmaceutical, nutraceutical and cosmeceutical Company that manufactures and markets generic drugs covering numerous treatment categories, announced: SOHM Announces Business Outlook for 2024 for each of its Business Units. SOHM, Inc. is organized into the following business units: -- OTC Self-care (over-the-counter nutraceuticals and cosmeceuticals) -- Branded Generics (off-patent prescription pharmaceuticals) -- CDMO, Co...

 PRESS RELEASE

SOHM Announces New CDMO GMP Manufacturing Facility in Carlsbad, Califo...

SOHM Announces New CDMO GMP Manufacturing Facility in Carlsbad, California CHINO HILLS, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced today its new manufacturing facility at Carlsbad.  SOHM Announces New CDMO GMP Manufacturing Facility in Carlsbad, California. The company is excited to announce the opening of a new facility in Carlsbad to meet the growing demand for its products. This facility will...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch